Acquisition of Rifampicin 600 MG PO SOL INJ AUE DG 1619
About This Opportunity
TranslatedThis tender pertains to the acquisition of Rifampicin 600 MG in the form of a parenteral solution for injection, designated as AUE DG 1619. Rifampicin is an essential antibiotic used primarily in the treatment of tuberculosis and other bacterial infections. The procurement is aimed at ensuring the availability of this critical medication within the healthcare system. Key requirements for bidders may include compliance with pharmaceutical standards, quality assurance certifications, and the ability to deliver the product within specified timelines. Additionally, bidders should demonstrate experience in supplying pharmaceutical products to governmental or health institutions. The location for the delivery of the product will be specified in the tender documents, and it is essential for bidders to adhere to all regulatory guidelines governing the procurement of medical supplies. This tender is significant for maintaining public health and ensuring that healthcare providers have access to necessary medications for effective treatment. Interested parties are encouraged to review the detailed tender documents for further information on submission deadlines, evaluation criteria, and any additional requirements that may apply.
This is a supplies contract in the health and medical services and trade and industry sectors, with a focus on Pharmaceuticals, Infectious Diseases and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 3,590.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "Aquisição de rifamPICina 600 MG PO SOL INJ AUE DG 1619" pertains to the procurement of rifampicin, a critical antibiotic used in the treatment of various bacterial infections, including tuberculosis.
This procurement initiative is part of an ongoing effort by the Portuguese healthcare system to ensure the availability of essential medications for public health needs.
This tender is being issued within the framework of public contracts in Portugal, as overseen by the relevant contracting authority. The primary objective is to acquire rifampicin in a formulation suitable for injection, specifically at a dosage of 600 MG. This specification underscores the urgency and necessity of maintaining an adequate supply of this medication within the national healthcare system.
Typical requirements for such a tender may include compliance with pharmaceutical standards, quality assurance measures, and adherence to regulatory guidelines set forth by health authorities. Suppliers are often expected to demonstrate their capacity to meet stringent delivery timelines and logistical considerations, ensuring timely access to the medication across various healthcare facilities. Additionally, bidders may be required to provide documentation regarding the safety and efficacy of the product, along with certifications of good manufacturing practices.
The tender represents a vital opportunity for pharmaceutical suppliers capable of meeting these demands within Portugal, aiming to contribute to the efficiency and effectiveness of the healthcare system in addressing public health challenges. Interested parties are encouraged to review the official tender documents for comprehensive details and submission guidelines.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 10, 2026. Last refreshed 9 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Alto Minho, EPE (ULSAM)
Unidade Local de Saúde do Alto Minho, EPE (ULSAM) has issued 512 procurement notices on BidsFactory, including 0 currently open and 462 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to DUXPHARMA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Alto Minho, EPE (ULSAM) in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €3,590. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.